 The injectable drug from biotech company Loyal aims to slow a canine growth hormone. The drug must now clear clinical trials. Loyal is pushing to have it on the market by 2026. Joining us now is Celine Hollywash. She's the CEO and founder of the San Francisco-based company Loyal. Celine, great to have you on the show.